181 related articles for article (PubMed ID: 18465244)
21. High efficacy of ranitidine bismuth citrate, amoxicillin, clarithromycin and metronidazole twice daily for only five days in Helicobacter pylori Eradication.
Gisbert JP; Marcos S; Gisbert JL; Pajares JM
Helicobacter; 2001 Jun; 6(2):157-62. PubMed ID: 11422472
[TBL] [Abstract][Full Text] [Related]
22. Moxifloxacin-based strategies for first-line treatment of Helicobacter pylori infection.
Nista EC; Candelli M; Zocco MA; Cazzato IA; Cremonini F; Ojetti V; Santoro M; Finizio R; Pignataro G; Cammarota G; Gasbarrini G; Gasbarrini A
Aliment Pharmacol Ther; 2005 May; 21(10):1241-7. PubMed ID: 15882245
[TBL] [Abstract][Full Text] [Related]
23. Seven-day triple therapy with ranitidine bismuth citrate or omeprazole and two antibiotics for eradication of Helicobacter pylori in duodenal ulcer: a multicentre, randomized, single-blind study.
Spinzi GC; Boni F; Bortoli A; Colombo E; Ballardini G; Venturelli R; Minoli G
Aliment Pharmacol Ther; 2000 Mar; 14(3):325-30. PubMed ID: 10735926
[TBL] [Abstract][Full Text] [Related]
24. Lansoprazole-based triple therapy versus ranitidine bismuth citrate-based dual therapy in the eradication of Helicobacter pylori in patients with duodenal ulcer: a multicenter, randomized, double-dummy study.
Luzza F; Giglio A; Ciliberto E; Belmonte A; Cavaliere C; Saccà N; Frandina C; Fiocca R; Trimboli V; Pallone F
Clin Ther; 2001 May; 23(5):761-70. PubMed ID: 11394734
[TBL] [Abstract][Full Text] [Related]
25. A multicenter, randomized, prospective study of 14-day ranitidine bismuth citrate- vs. lansoprazole-based triple therapy for the eradication of Helicobacter pylori in dyspeptic patients.
Avşar E; Tiftikçi A; Poturoğlu S; Erzin Y; Kocakaya O; Dinçer D; Yıldırım B; Güliter S; Türkay C; Yılmaz U; Onuk MD; Bölükbaş C; Ellidokuz E; Bektaş A; Taşan G; Aytuğ N; Ateş Y; Kaymakoğlu S
Turk J Gastroenterol; 2013; 24(4):316-21. PubMed ID: 24254262
[TBL] [Abstract][Full Text] [Related]
26. Optimal treatment of Helicobacter pylori with ranitidine bismuth citrate (RBC): a randomized comparison between two 7-day triple therapies and a 14-day dual therapy.
de Boer WA; Haeck PW; Otten MH; Mulder CJ
Am J Gastroenterol; 1998 Jul; 93(7):1101-7. PubMed ID: 9672338
[TBL] [Abstract][Full Text] [Related]
27. Long-term follow up Helicobacter Pylori reinfection rate after second-line treatment: bismuth-containing quadruple therapy versus moxifloxacin-based triple therapy.
Kim MS; Kim N; Kim SE; Jo HJ; Shin CM; Park YS; Lee DH
BMC Gastroenterol; 2013 Sep; 13():138. PubMed ID: 24050512
[TBL] [Abstract][Full Text] [Related]
28. Comparison of bismuth-containing quadruple and concomitant therapies as a first-line treatment option for Helicobacter pylori.
Kadayifci A; Uygun A; Polat Z; Kantarcioğlu M; Kılcıler G; Başer O; Ozcan A; Emer O
Turk J Gastroenterol; 2012 Feb; 23(1):8-13. PubMed ID: 22505373
[TBL] [Abstract][Full Text] [Related]
29. One-week therapy with pantoprazole versus ranitidine bismuth citrate plus two antibiotics for Helicobacter pylori eradication.
Gisbert JP; Carpio D; Marcos S; Gisbert JL; García Grávalos R; Pajares JM
Eur J Gastroenterol Hepatol; 2000 May; 12(5):489-95. PubMed ID: 10833090
[TBL] [Abstract][Full Text] [Related]
30. Randomized trial on 14 versus 7 days of esomeprazole, moxifloxacin, and amoxicillin for second-line or rescue treatment of Helicobacter pylori infection.
Miehlke S; Krasz S; Schneider-Brachert W; Kuhlisch E; Berning M; Madisch A; Laass MW; Neumeyer M; Jebens C; Zekorn C; Knoth H; Vieth M; Stolte M; Lehn N; Morgner A
Helicobacter; 2011 Dec; 16(6):420-6. PubMed ID: 22059392
[TBL] [Abstract][Full Text] [Related]
31. Comparison of 1-week vs. 2- or 4-week therapy regimens with ranitidine bismuth citrate plus two antibiotics for Helicobacter pylori eradication.
Kamberoglou D; Polymeros D; Sanidas I; Doulgeroglou V; Savva S; Patra E; Tzias V
Aliment Pharmacol Ther; 2001 Sep; 15(9):1493-7. PubMed ID: 11552924
[TBL] [Abstract][Full Text] [Related]
32. Ranitidine-bismuth citrate, tetracycline and metronidazole followed by triple therapy as alternative strategy for Helicobacter pylori treatment: a pilot study.
Calvet X; Montserrat A; Güell M; Vergara M; Gené E
Eur J Gastroenterol Hepatol; 2004 Oct; 16(10):987-90. PubMed ID: 15371921
[TBL] [Abstract][Full Text] [Related]
33. Ranitidine bismuth citrate-based triple therapies after failure of the standard 'Maastricht triple therapy': a promising alternative to the quadruple therapy?
Perri F; Villani MR; Quitadamo M; Annese V; Niro GA; Andriulli A
Aliment Pharmacol Ther; 2001 Jul; 15(7):1017-22. PubMed ID: 11421877
[TBL] [Abstract][Full Text] [Related]
34. Ranitidine bismuth citrate versus omeprazole triple therapy for the eradication of Helicobacter pylori and healing of duodenal ulcer.
Catalano F; Catanzaro R; Bentivegna C; Brogna A; Condorelli G; Cipolla R
Aliment Pharmacol Ther; 1998 Jan; 12(1):59-62. PubMed ID: 9692702
[TBL] [Abstract][Full Text] [Related]
35. One-week use of ranitidine bismuth citrate, amoxycillin and clarithromycin for the treatment of Helicobacter pylori-related duodenal ulcer.
Sung JJ; Leung WK; Ling TK; Yung MY; Chan FK; Lee YT; Cheng AF; Chung SC
Aliment Pharmacol Ther; 1998 Aug; 12(8):725-30. PubMed ID: 9726384
[TBL] [Abstract][Full Text] [Related]
36. Helicobacter pylori eradication: proton pump inhibitor vs. ranitidine bismuth citrate plus two antibiotics for 1 week-a meta-analysis of efficacy.
Gisbert JP; González L; Calvet X; Roqué M; Gabriel R; Pajares JM
Aliment Pharmacol Ther; 2000 Sep; 14(9):1141-50. PubMed ID: 10971230
[TBL] [Abstract][Full Text] [Related]
37. Salvage therapies after failure of Helicobacter pylori eradication with ranitidine bismuth citrate-based therapies.
Chan FK; Sung JJ; Suen R; Wu JC; Ling TK; Chung SC
Aliment Pharmacol Ther; 2000 Jan; 14(1):91-5. PubMed ID: 10632651
[TBL] [Abstract][Full Text] [Related]
38. Second-line treatment for Helicobacter pylori infection based on moxifloxacin triple therapy: a randomized controlled trial.
Bago J; Pevec B; Tomić M; Marusić M; Bakula V; Bago P
Wien Klin Wochenschr; 2009; 121(1-2):47-52. PubMed ID: 19263014
[TBL] [Abstract][Full Text] [Related]
39. Amoxicillin/tetracycline combinations are inadequate as alternative therapies for Helicobacter pylori infection.
Perri F; Festa V; Merla A; Quitadamo M; Clemente R; Andriulli A
Helicobacter; 2002 Apr; 7(2):99-104. PubMed ID: 11966868
[TBL] [Abstract][Full Text] [Related]
40. Systematic review and meta-analysis: proton pump inhibitor vs. ranitidine bismuth citrate plus two antibiotics in Helicobacter pylori eradication.
Gisbert JP; Gonzalez L; Calvet X
Helicobacter; 2005 Jun; 10(3):157-71. PubMed ID: 15904473
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
